CTLA-4/PD-1, LAG-3, and TIGIT Inhibitors: Emerging Drug Targets and Combination Strategies in Hepatocellular Carcinoma
Current Cancer Drug Targets
Research outputs
مقالات ومراجعات وأوراق مؤتمرات وفصول كتب، مفهرسة برقم DOI ومربوطة بباحثي الجامعة.
6 مُخرَج نتائج البحث عن «Cancer research»
Current Cancer Drug Targets
Scientific Reports · مجلد 14 (1) · 31764-31764
Cervical cancer is one of the deadly diseases that affects women, which requires periodic examinations to identify and treat any cancerous tumors at a preliminary stage. The most prevalent examination tool for cervical cancer prompt identification is the cervical smear (Pap smear) testing; however, due to human negligence, this examination method has an elevated probability of negative findings. Cervical cancer classification using machine learning (ML) and deep learning (DL) has been extensively studied to enhance the conventional diagnostic process. Robust classification results were achieved through the pre-segmented imagery in most current investigations. Conversely, cellular grouping makes reliable cervical cellular segmentation difficult. Additionally, the deep learning methods used in the existing works perform poorly on a multiclass classification when the data distribution is skewed, which is common in the cervical cancer dataset. To mitigate these restrictions in cervical cancer research, this proposed work uses a combination of four different deep-learning methods in various phases of this research. The proposed work is segregated into five phases: pre-processing, data augmentation, segmentation, feature extraction, and classification. Contrast maximization is performed in the pre-processing phase, and the images are augmented using Multi-modal Generative Adversarial Networks (m-GAN) in the second phase. In the third phase, cervical cancer images are segmented using the Seg-UNet model, which is forwarded to the feature extraction phase that employs denoising autoencoders. Finally, the classification is implemented using the Dense CapsNet model and applied to the SIPaKMeD dataset to categorize between normal, abnormal, and benign classes. The proposed system achieves an accuracy of 99.65%, which is higher than the other works in the literature.
RSC Advances · مجلد 14 (48) · 35505-35519
OBJECTIVE: analyses. METHODS: )-ylidene)hydrazono) ethyl) phenyl) benzamide) on cell cycle arrest and apoptosis induction. Furthermore, computational investigations, including molecular docking, MD simulations, DFT calculations, MM-GBSA, PCAT, and ADMET predictions were conducted. RESULTS: 0.19 μM). Mechanistic studies revealed its ability to arrest the cell cycle of MCF-7 cells and induce apoptosis (total apoptosis 34.47%, early apoptosis 18.48%, and late apoptosis 15.99%), supported by upregulated caspase-8 (3.42-fold) and caspase-9 (5.44-fold) expression. Additionally, 20b arrested the cell cycle of MCF-7 cells at the %G0-G1 phase. Computational investigations provided insights into its molecular interactions with VEGFR-2, contributing to the rational design and understanding of its pharmacological profile. CONCLUSIONS: Compound 20b presents as a promising anti-proliferative agent targeting VEGFR-2. Also, this comprehensive investigation underscores the potential of 2,3-dihydro-1,3,4-thiadiazole derivatives as promising candidates for further development in anti-cancer research.
Journal of King Saud University - Science · مجلد 36 (11) · 103536-103536
This study introduces a sustainable method for producing silver nanoparticles (AgNPs), focusing on sustainability and environmental protection.The technique includes the use of Salvia elegans aqueous leaf extract as a reducing agent.In addition, the research investigates the dose-dependent degradation of pUC19 DNA by silver nanoparticles, which is facilitated by the generation of singlet oxygen.The presence of S. elegans extract results in significant color changes, going from a colorless state to a dark brown hue, serving as an indication of the synthesis of AgNPs.A range of experimental methods were employed to analyze the biogenic AgNPs, such as UV-visible absorption spectroscopy, X-ray diffraction (XRD), transmission electron microscopy (TEM) and scanning electron microscopy (SEM).The meticulously produced AgNPs demonstrate a high level of uniformity, featuring a spherical shape and a particle size of 60 nm.DNA photo-cleavage studies show that singlet oxygen plays a crucial role in triggering DNA damage caused by AgNPs, indicating their potential as powerful cytotoxic agents specifically aimed at cancer cells.Additional studies are required to clarify the effectiveness and specificity of AgNPs against various cancer cell types to assess their therapeutic potential.The cytotoxic effects of AgNPs, particularly in relation to DNA photocleavage, are of considerable interest in cancer research.This research holds promise for developing novel and sustainable cancer therapies based on the unique properties of biogenic silver nanoparticles.
Results in Chemistry · مجلد 7 · 101264-101264
The application of nanotechnology to cancer research has resulted in substantial advancements. In this study, gold nanoparticles (AuNPs) synthesised utilising environmentally friendly methods are evaluated for their potential as multipurpose theranostic agents in cancer treatment. These eco-friendly AuNPs are attractive candidates for theranostic applications that combine diagnosis and therapy due to their specific physicochemical features. Green nanotechnology practises that use only sustainable, biocompatible materials promote biocompatibility in biomedical applications while reducing environmental impact. Imaging techniques such as optical coherence tomography, surface-enhanced Raman scattering, and photoacoustic imaging can benefit from AuNPs in part due to their optical properties. Their surface plasmon resonance (SPR) can be adjusted, improving imaging contrast and allowing for tailored administration of therapeutic payloads. The localised SPR effect of AuNPs also increases the efficacy of photothermal treatment (PTT) by converting near-infrared light into localised heat and inducing hyperthermia in cancer cells. Because of the localised heating, the cancer may be ablated precisely and with minimal collateral damage. AuNPs can be observed and assessed in real time as part of a multimodal imaging platform, in addition to being used as diagnostic and therapeutic tools. The primary focus of this research is on recent breakthroughs in the production of AuNPs using green nanotechnology techniques, particularly those that have occurred beyond 2020, and their potential applications in cancer theranostics. We are investigating various techniques for functionalizing AuNPs with specific ligands, medications, and imaging agents in order to improve therapeutic efficacy. We also go over the regulatory considerations and toxicity assessments that must be considered when bringing these nanomaterials into clinical use, as well as the potential that exist.
Life · مجلد 11 (10) · 1070-1070
The vascular endothelial growth factor receptor 2 (VEGFR-2) is largely recognized as a potent therapeutic molecular target for the development of angiogenesis-related tumor treatment. Tumor growth, metastasis and multidrug resistance highly depends on the angiogenesis and drug discovery of the potential small molecules targeting VEGFR-2, with the potential anti-angiogenic activity being of high interest to anti-cancer research. Multiple small molecule inhibitors of the VEGFR-2 are approved for the treatment of different type of cancers, with one of the most recent, tivozanib, being approved by the FDA for the treatment of relapsed or refractory advanced renal cell carcinoma (RCC). However, the endogenous and acquired resistance of the protein, toxicity of compounds and wide range of side effects still remain critical issues, which lead to the short-term clinical effects and failure of antiangiogenic drugs. We applied a combination of computational methods and approaches for drug design and discovery with the goal of finding novel, potential and small molecule inhibitors of VEGFR2, as alternatives to the known inhibitors' chemical scaffolds and components. From studying several of these compounds, the derivatives of pyrido[1,2-a]pyrimidin-4-one and isoindoline-1,3-dione in particular were identified.